SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-022364
Filing Date
2014-04-14
Accepted
2014-04-14 12:53:27
Documents
8
Period of Report
2014-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v374419_8k.htm 8-K 24011
2 EXHIBIT 4.1 v374419_ex4-1.htm EX-4.1 99117
3 EXHIBIT 5.1 v374419_ex5-1.htm EX-5.1 9593
4 EXHIBIT 10.1 v374419_ex10-1.htm EX-10.1 212048
5 EXHIBIT 10.2 v374419_ex10-2.htm EX-10.2 81316
6 EXHIBIT 99.1 v374419_ex99-1.htm EX-99.1 14870
7 GRAPHIC image_001.jpg GRAPHIC 2361
8 GRAPHIC image_007.jpg GRAPHIC 3438
  Complete submission text file 0001144204-14-022364.txt   450425
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 14761920
SIC: 2834 Pharmaceutical Preparations